UTHR

United Therapeutics Corp.

497.11

-6.75-1.34%

After Hours: 497.11 0.00 0.00%19:30 09/11 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE506.78/497.11

TODAY RANGE499.62-509.07

VOL4

MARKET CAP21.56B

52 WEEK RANGE396.12-609.35

AVG VOL (3M)528.68K

% TURNOVER0.78%

TURNOVER0

P/E (TTM)17.98

% RANGE1.90%

EPS(TTM)27.96

P/E(FORWARD)19.30

P/B3.352

BVPS149.97

DIVIDEND--

P/S6.89

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP21.11B

SHARES OUTSTANDING42.89M

NEXT EARNINGS10/27-11/02

FREE FLOAT41.99M

LOT SIZE1

EX-DATE09/23/2009

News

Press Releases

Financial Reports

Profile

TipRanks·3d ago
These 3 ETFs Could Deliver Over 12% Upside, According to the AI Analyst
TipRanks·5d ago
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), United Therapeutics (UTHR) and Spyre Therapeutics (SYRE)
TipRanks·6d ago
United Therapeutics Announces New Accelerated Share Repurchase
Seeking Alpha·09/08 11:50
United Therapeutics enters $477.6M accelerated share repurchase
TipRanks·09/08 11:05
United Therapeutics announces accelerated share repurchase agreement
Dow Jones·09/08 11:00
*United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement For Remainder Of $2.0 Billion Authorization >UTHR
NASDAQ·09/03 15:43
FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
TipRanks·09/02 15:05
Wells Fargo Reaffirms Their Buy Rating on United Therapeutics (UTHR)
TipRanks·09/02 12:50
Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (UTHR) and Medtronic (MDT)
Seeking Alpha·09/02 12:24
United Therapeutics bid to expand nebulized Tyvaso label gets FDA review
Seeking Alpha·09/02 12:02
Ten healthcare stocks leading in year-over-year CapEx growth
NASDAQ·09/02 11:58
United Therapeutics Announces FDA Acceptance Of SNDA For Nebulized Tyvaso In IPF
TipRanks·09/02 11:05
United Therapeutics announces FDA accepted sNDA for Tyvaso
NASDAQ·09/01 20:39
Top Research Reports for Toyota Motor, CrowdStrike & Welltower
Seeking Alpha·08/31 18:57
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know

Same Industry

Name/Symbol

Change%

Price

MCK

Biogen Inc

BIIB

+0.80%

217.15

Amgen Inc

AMGN

-1.34%

377.35

SHPG

CELG-RT

Lilly Eli & Co

LLY

-0.65%

CELG

Therapeuticsmd Inc

TXMD

+2.86%

2.160

Johnson & Johnson

JNJ

-0.29%

265.58

ABBV

ZTS

Gilead Sciences Inc

GILD

+1.87%

146.41

NVO

Bristol-Myers Squibb Co

BMY

-0.17%

63.64

ALXN

Pfizer

PFE

+0.25%

27.72

Sanofi FR

SNY

+0.12%

42.77

GCVRZ

NVS

Dr Reddys Labs

RDY

-0.04%

11.90

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.